← Back to blog
DividendJune 17, 2026

Dividend Win Wednesday: Semiconductor Capital Equipment at 7× Earnings and 88% Off Peak

Top 5 Pixie Picks

Only Pro and Free Trial readers get meta-analysis of the top 5 ranked Dividend stocks.

Sign in

6. Biogen Inc. (BIIB

Dividend yield: n/a | Payout ratio: 0.0% | 52w drawdown: -3.4%

Biogen shows a 6.7% FCF yield with 76% gross margin, 2.2% revenue growth, and 7% ROIC. The stock is only 3.4% off its 52-week high, trading near $199 against a $219 analyst target for 10% implied upside.

Insiders added 84,208 net shares over six months with a 50.4% buy ratio, the highest conviction signal among the eight names this week. Jesus Mantas, Lloyd Minor, and Maria Freire all filed buys in June; insider dollar volume totals $16.8 million.

The company pays no dividend despite the 6.7% FCF yield, which makes this a capital-appreciation trade, not an income position. Interest coverage at 6.8× is the lowest among the biotech and pharma names on the screen, and net debt/EBITDA at 0.64 means the balance sheet carries leverage.

7. Gilead Sciences, Inc. (GILD)

Dividend yield: 2.6% | Payout ratio: 47.9% | 52w drawdown: -19.4%

Gilead trades at a 6.0% FCF yield with 24.4% ROIC, 79% gross margin, and 2.4% revenue growth. The payout ratio is 47.9%, leaving half the free cash for buybacks or pipeline investment; shareholder yield including repurchases is 1.2%.

Insiders added 283,785 net shares over six months, with Andrew Dickinson and Johanna Mercier filing buys in mid-June. The insider buy ratio is 53% against 30% sells, a net positive signal. News this week showed insider sales totaling $376,200, but the six-month net remains positive.

The stock is down 19.4% from its 52-week high, trading at $126.77 against a $157.83 analyst target for 24.5% implied upside. Next earnings on August 6 show consensus at negative $7.14 EPS, which reflects a one-time charge or restructuring; revenue estimate is $7.4 billion.

8. Exxon Mobil Corporation (XOM)

Dividend yield: 2.9% | Payout ratio: 59.2% | 52w drawdown: -19.9%

Exxon shows a 4.0% FCF yield with 69× interest coverage, the highest debt-service cushion on the screen. ROIC is 11.1%, gross margin is 22%, and the payout ratio is 59%, which funds a 2.9% yield with room for modest growth.

Revenue declined 4.5% year-over-year and the five-year dividend CAGR is negative 10%, which means this is a stability play on energy sector exposure, not a growth dividend. The stock is down 20% from peak and trades at $141 against a $169.91 analyst target for 20% implied upside.

Jeffrey Ubben added 32,250 net shares in late May, the only insider activity in the last 30 days. Western Midstream brought a second produced-water facility online in the Permian this week, expanding the infrastructure footprint for Exxon's basin partners.


What to Watch

  • July 21: Novartis earnings (est. $2.11 EPS, $14.1B revenue). Revenue growth at 9.6% year-over-year means consensus is pricing modest expansion; any upside surprise moves the dividend growth narrative.
  • July 23: Newmont earnings (est. $2.26 EPS, $6.5B revenue). The new CEO and CFO report their first quarter after the leadership reshuffle; gross margin at 53% sets the bar for operational improvement.
  • July 29: Biogen earnings (est. $2.03 EPS, $2.4B revenue). Insiders added $16.8 million in the last six months; the neurology franchise and Alzheimer's pipeline will determine whether the FCF yield holds.
  • July 30: KLA earnings (est. $1.00 EPS, $3.6B revenue). The semiconductor capital equipment sector trades at 7× to 10× forward earnings after the 88% drawdown; any upside on WFE demand sends the stock toward analyst targets above $1,800.

Go Deeper

The dividend screener looks for companies with high free cash flow yields, sustainable payout ratios, and drawdowns that create entry points below fair value.

Check out the full screener →

Pro-only analytics

Named tickers from this article open in the app with Pro or an active trial.

Sign in

Stock Pixie Pro

See the full dividend screen — every pick, every metric, every day.

The app shows up to 10 rows on Free; the top 5 by Pixie rank keep ticker, name, and recent close private. Posts may name the top 5 for context. Pro and trial show every row on the screener, full identifiers, and the rest of Pro.

Start your free trial

About the Stock Pixie Score

The Stock Pixie Score is a 0–10 composite that measures how well a stock matches the criteria for that screen. Scores reflect the strength of quantitative signals across valuation, quality, and trend factors weighted for the specific screener. A higher score means stronger alignment; above 8 indicates the algorithm finds the setup compelling across most of the metrics it tracks. It is a filter, not a forecast.

The Fine Print

Stock Pixie is not a registered investment adviser and does not offer financial advice. It is a stock screening platform that scores and ranks stocks using quantitative signals. You are responsible for your own research and investment decisions. Past performance does not guarantee future results.